Vaccinex (VCNX) Misses Q3 EPS by 83c

Vaccinex (NASDAQ: VCNX) reported Q3 EPS of ($1.09), $0.83 worse than the analyst estimate of ($0.26). Revenue for the quarter came in at $20 thousand versus the consensus estimate of $0 .

For earnings history and earnings-related data on Vaccinex (VCNX) click here.

You May Also Be Interested In

• AngioDynamics (ANGO) Tops Q4 EPS by 2c ; Offers Guidance
• Mainframe shift weighs on Big Blue: IBM drops 14% on Q2 shortfall
• Wells Fargo (WFC) Tops Q2 EPS by 28c, Beats on Revene